XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Operations - USD ($)
 3 Months Ended 6 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2019
Mar. 31, 2018
Income Statement [Abstract]        
Revenues, net $ 723,899 $ 120,265 $ 986,806 $ 138,345
Cost of revenues 592,018 77,277 815,344 83,745
Gross profit 131,881 42,988 171,462 54,600
Operating expenses        
Professional fees 1,406,269 331,891 2,422,276 486,892
Payroll expenses 313,170 107,775 473,521 365,973
Product development 341,081 357,345 689,741 702,662
Research and development 646 2,961
General and administrative expenses 159,408 64,566 256,397 140,508
Depreciation and amortization 499,636 207,519 657,119 422,742
Total operating expenses 2,719,564 1,069,742 4,499,054 2,121,738
Loss from operations (2,587,683) (1,026,754) (4,327,592) (2,067,138)
Other income (expense)        
Gain (loss) on settlement of debt 6,800 (19,425)
Gain (loss) on derivative liability (64,700) (64,700)
Interest expense (5,183,657) (33,288) (5,701,074) (49,419)
Total other income (expense) (5,176,857) (97,988) (5,720,499) (114,119)
Net loss $ (7,764,540) $ (1,124,742) $ (10,048,091) $ (2,181,257)
Basic loss per common share $ (0.19) $ (0.03) $ (0.26) $ (0.06)
Basic weighted average common shares outstanding 41,219,633 33,766,781 38,848,179 34,039,090